BioSpace News Archive

Aptose to Present at the H.C. Wainwright 24th Annual Global Investment Conference

Aptose Biosciences Inc. today announced that the Aptose management team will participate in the H.C. Wainwright 24th Annual Global Investment Conference being held in-person and virtually September 12-14, 2022, in New York City.

August 30, 2022
·
3 min read
BioForest

Nautilus Biotechnology to Participate in the Morgan Stanley Global Healthcare Conference

Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the proteome, today announced the company will be participating in the upcoming Morgan Stanley Global Healthcare Conference in New York, NY.

August 30, 2022
·
1 min read
Biotech Bay

AMGEN TO PRESENT NEW, POSITIVE CLINICAL AND REAL-WORLD DATA ACROSS INFLAMMATION PORTFOLIO AT EADV 2022

Amgen (NASDAQ:AMGN) today announced that clinical and real-world data from across its inflammation portfolio, including both established treatments and pipeline assets, will be presented at the 31st European Academy of Dermatology and Venereology (EADV), taking place in Milan, Italy, Sept. 7-10, 2022.

August 30, 2022
·
28 min read
Business

Illumina Deepens Commitment to Customers in China with New Manufacturing Site

Illumina, Inc., a global leader in DNA sequencing and array-based technologies, announced the opening of its first manufacturing site in China.

August 30, 2022
·
2 min read
Policy

Press Release: FDA grants priority review to efanesoctocog alfa for people with hemophilia A

The U.S. Food and Drug Administration has accepted for priority review the Biologics License Application for efanesoctocog alfa for the treatment of hemophilia A, a rare and life-threatening bleeding disorder.

August 30, 2022
·
9 min read
AlzeCure Gets Abstract Accepted on Potential Neuroprotective Effects of NeuroRestore ACD856

AlzeCure Pharma AB announced that an abstract about the research platform NeuroRestore and its role in neuroprotection has been accepted for a presentation at ISMND 2022, which this year will be held in Athens, Greece, on October 10-12.

August 30, 2022
·
5 min read
Drug Development

OKYO Pharma Plans Q4 2022 IND Filing of OK-101 to treat Dry Eye Disease with Subsequent Phase 2 Initiation Alongside Peptide Manufacturing Partner, AmbioPharm

OKYO Pharma Limited, a biotechnology company focused on the discovery and development of novel molecules to treat inflammatory dry eye diseases and ocular pain, plans aQ4 2022 IND filingfor OK-101 to treat dry eye disease, with AmbioPharm playing a key role in peptide manufacturing and development.

August 30, 2022
·
5 min read
Business

Procaps Group Reports Second Quarter and First Half 2022 Results

Procaps Group S.A., a leading integrated LatAm healthcare and pharmaceutical conglomerate, announced its financial results for the three months ended June 30, 2022 and the six months ended June 30, 2022.

August 30, 2022
·
9 min read
Biotech Bay

Aria Pharmaceuticals Advances Pipeline with Six Provisional US Patents Filed Across Three Diseases

Aria Pharmaceuticals announced that the company has successfully filed a total of six provisional patents with the United States Patent and Trademark Office (USPTO) for lead candidates in its lupus, idiopathic pulmonary fibrosis (IPF), and chronic kidney disease (CKD) research programs.

August 30, 2022
·
3 min read
Biotech Bay

Veranex Accelerating Clinical Trials with Veeva Vault CDMS

Veeva Systems (NYSE: VEEV) today announced that Veranex is using Veeva Vault CDMS to speed study builds and simplify clinical data management.

August 30, 2022
·
3 min read